HMGB1 and cancer: HMGB1 and HMGB2 not only differently affect the cellular activity of telomerase in etoposide-untreated or -treated hESCs and hNECs [10,17], but the proteins also differentially modulate the sensitivity of cancer cells to distinct anticancer drugs.